Natural Product (NP) Details
General Information of the NP (ID: NP7822) | |||||
---|---|---|---|---|---|
Name |
Pancratistatin
|
||||
Synonyms |
Pancratistatin; 96203-70-2; CHEBI:7906; (+)-Pancratistatin; NSC349156; MLS002701837; (1R,2S,3S,4S,4aR,11bR)-1,2,3,4,7-pentahydroxy-2,3,4,4a,5,11b-hexahydro-1H-[1,3]dioxolo[4,5-j]phenanthridin-6-one; SCHEMBL93612; CHEMBL419335; ZINC4097654; NSC-349156; SMP1_000217; NCI60_003105; B844009K070; C08535; Q7130395; [1,5-j]phenanthridin-6(2H)-one, 1,3,4,4a,5,11b-hexahydro-1,2,3,4,7-pentahydroxy-,
Click to Show/Hide
|
||||
Species Origin | Pancratium littorale ... | Click to Show/Hide | |||
Pancratium littorale | |||||
Disease | Colorectal cancer [ICD-11: 2B91] | Investigative | [1] | ||
Structure |
![]() |
Click to Download Mol2D MOL |
|||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C14H15NO8
|
||||
PubChem CID | |||||
Canonical SMILES |
C1OC2=C(O1)C(=C3C(=C2)C4C(C(C(C(C4O)O)O)O)NC3=O)O
|
||||
InChI |
1S/C14H15NO8/c16-8-5-3-1-4-13(23-2-22-4)9(17)6(3)14(21)15-7(5)10(18)12(20)11(8)19/h1,5,7-8,10-12,16-20H,2H2,(H,15,21)/t5-,7-,8-,10+,11+,12+/m1/s1
|
||||
InChIKey |
VREZDOWOLGNDPW-ALTGWBOUSA-N
|
||||
CAS Number |
CAS 96203-70-2
|
||||
ChEBI ID | |||||
Herb ID | |||||
SymMap ID | |||||
TCMSP ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
Tamoxifen | Breast cancer | Click to Show/Hide the Molecular Data of This Drug | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) |
Combination Info
![]() |
|||||
Biological
Regulation |
Increase | ROS generation | ||||
In-vitro Model | MCF-7 | CVCL_0031 | Invasive breast carcinoma | Homo sapiens | ||
Experimental
Result(s) |
In combination with the anti-estrogen Tamoxifen, PST had a synergic effect. |
